Jasper Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,174 |
Gross Profit | -258 | -279 | 587 | |
EBITDA | -18,507 | -26,818 | -21,523 | -25,040 |
EBIT | -18,736 | -27,076 | -21,802 | -25,285 |
Net Income | -18,736 | -26,723 | -21,241 | -24,321 |
Net Change In Cash | 0 | 0 | 0 | 1,174 |
Free Cash Flow | -16,999 | -15,460 | -22,842 | -21,230 |
Cash | 50,899 | 39,510 | 48,799 | 71,637 |
Basic Shares | 16,635 | 15,333 | 15,022 | 15,008 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $13,511 | $6,196 |
Gross Profit | -1,373 | -1,108 | -1,310 | -566 |
EBITDA | -74,866 | -67,753 | -50,221 | -36,456 |
EBIT | -76,239 | -68,861 | -51,196 | -36,833 |
Net Income | -71,269 | -64,465 | -37,685 | -30,637 |
Net Change In Cash | 0 | 0 | 13,511 | 6,196 |
Cost of Revenue | -46,379 | 64,863 | ||
Free Cash Flow | -63,154 | -52,334 | -46,434 | -36,106 |
Cash | 71,637 | 86,887 | 38,250 | 84,701 |
Basic Shares | 14,584 | 10,439 | 3,648 | 1,139 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.13 |
2025-06-30 | -$1.74 |
2025-03-31 | -$1.41 |
2024-12-31 | -$1.62 |
